Related Experiment Videos
Effects of oral antihypertensive agents on blood lipid levels
Insights
Lowering blood pressure with certain drugs may increase coronary heart disease risk by affecting lipid levels. Reappraising antihypertensive therapies to consider metabolic effects is crucial for primary prevention.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Preventive Cardiology
Background:
- Lowering serum cholesterol demonstrably reduces coronary heart disease (CHD) incidence.
- Many blood pressure-lowering drugs negatively impact serum lipid levels.
- Some antihypertensive agents, like beta-blockers and diuretics, show limited primary CHD prevention and may increase risk.
Purpose of the Study:
- To review recent clinical trials on the effects of antihypertensive drugs on lipid levels.
- To emphasize the need for reappraising current therapeutic schemes for hypertension.
- To highlight the importance of considering metabolic effects, especially on lipids, in antihypertensive drug selection.
Main Methods:
- Review of recent clinical trials.
- Analysis of studies examining the effects of diuretics, beta-blockers, and selective alpha-adrenoceptor blocking agents on blood lipids.
- Evaluation of primary preventive effects on coronary heart disease.
Main Results:
- Certain pharmacological agents used to lower blood pressure adversely affect serum lipid levels.
- Prolonged use of beta-blockers and diuretics has not shown clear primary preventive effects on CHD.
- Some antihypertensive treatments may pose a greater CHD risk than no treatment.
Conclusions:
- Primary preventive therapy for CHD must extend beyond blood pressure reduction.
- The metabolic effects of antihypertensive drugs, particularly on blood lipids, require careful consideration.
- This approach is especially significant for younger patients with long-term CHD risk.
Abstract:
The Lipid Research Clinic trials established conclusively that lowering serum cholesterol reduces the incidence of coronary heart disease. Yet a number of clinical trials have demonstrated that many pharmacological agents commonly used to lower blood pressure also adversely affect serum lipid levels. Recent studies of prolonged use of beta-blockers and diuretics have failed to show that these agents have any clear primary preventive effect on coronary heart disease; in a few cases, these agents were believed to pose a greater risk of coronary heart disease than no antihypertensive treatment at all. These observations suggest that a reappraisal of current therapeutic schemes is in order. Because coronary heart disease is known to have many causes, primary preventive therapy must logically go beyond the relatively simple goal of lowering blood pressure. The metabolic effects of antihypertensive drugs, particularly on blood lipids, should also be taken into account. These effects could be of special clinical significance in relatively young patients, for whom the long-term risk of developing coronary heart disease is of major concern. This review discusses recent clinical trials examining the effects on lipids of diuretics, beta-blockers, and selective alpha-adrenoceptor blocking agents.